Therapix Biosciences

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.

Aphria

Greenlane Holdings

HEXO Corp

Innovative Industrial Properties

OrganiGram Holdings Inc.

SNDL Inc.

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks over the past week, and look ahead to how the cannabis industry will develop in the new year.

7 Cannabis Stocks Already on Fire the First Week of 2021

Aurora Cannabis

Arena Pharmaceuticals

GW Pharmaceuticals

New Age Beverages

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead at the pot stocks to watch in the upcoming week.

9 Pot Stocks That Made Big Moves This Week

TEL AVIV, Israel, July 1, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) (the "Company" or "Therapix"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today receipt of Notice of Delisting and...

Therapix Biosciences Receives Notice of Delisting and Injunction from Israeli Court

TEL-AVIV, Israel, June 29, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced that it has entered into definitive...

Therapix Biosciences Raises $2.6 Million in Private Placement

Cara Therapeutics

Corbus Pharmaceuticals Holdings

Cronos Group

Marrone Bio Innovations

Intec Parent

Psychemedics

Tilray Brands

Village Farms International

Zynerba Pharmaceuticals

The cannabis industry has grown in recent months and years, and many companies in the cannabis and health-related industries have been uplisted to reputable U.S. exchanges.

Top Marijuana Stocks on the NASDAQ

Shares of Therapix Biosciences fell 5% in morning trading after the Israeli drugmaker said it would continue to test its experimental cannabinoid-based therapy as an autism treatment.

Therapix shares fall as it moves forward with cannabinoid drug

Cannabis-focused investment company SOL Global Investments Corp. (CSE: SOL) said Tuesday that its portfolio company, Heavenly Rx, Ltd., has entered into a memorandum of understanding with Therapix Biosciences Ltd to chase a business combination.

Therapix Pursues Reverse Merger With CBD Wellness Company Heavenly Rx

Canopy Growth

There is a lot of hype regarding CBD and a lack of regulatory clarity. I discuss the big issues and identify some of the better players in the space among public-traded companies.

News for Therapix Biosciences Stock (TRPX)